CONRIG PHARMA ApS: Financial statements 2013
CVR: 33373236
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -227,519 and a net result of DKK -274,036 compared with DKK -243,991 the year before. Equity in the 2013 report amounted to DKK 275,528. The solvency ratio was 91.1%.
- Gross Profit
- DKK -227,519
- Profit/Loss
- DKK -274,036
- Equity
- DKK 275,528
- Total Assets
- DKK 302,384
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -228 t. | -274 t. | 276 t. | - |
| 2012 | - | -266 t. | -244 t. | 200 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
CONRIG PHARMA ApS has published its annual report for 2012. Gross profit came to DKK -265,781, and the net result was DKK -243,991.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.